#pirtobrutinib

1 story

#blood cancer #btk inhibitor #chronic lymphocytic leukemia #fda approval #health #jaypirca #medicine #small lymphocytic lymphoma

FDA approves Jaypirca for untreated blood cancers
The drug pirtobrutinib gains approval for first-time treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma in patients without a 17p deletion.
WebMD · 1m